Bacterial vaccine - Ab&b Biotech
Latest Information Update: 06 Mar 2024
At a glance
- Originator Ab&B Biotech
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Bacterial infections
Most Recent Events
- 18 Dec 2023 Early research in Bacterial infections (Prevention) in China (unspecified route) (Ab&b Biotech pipeline, December 2023)